By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Aspire Biopharma Holdings, Inc. (ASBP)

NASDAQ Currency in USD
$0.45
+$0.01
+1.57%
Last Update: 11 Sept 2025, 20:00
$22.36M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.22 - $15.80
52 Week Range

ASBP Stock Price Chart

Explore Aspire Biopharma Holdings, Inc. interactive price chart. Choose custom timeframes to analyze ASBP price movements and trends.

ASBP Company Profile

Discover essential business fundamentals and corporate details for Aspire Biopharma Holdings, Inc. (ASBP) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

11 Apr 2022

Employees

2.00

CEO

Kraig T. Higginson

Description

Aspire Biopharma Holdings, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge research in genetics and biochemistry to support healthcare and life sciences industries.

ASBP Financial Timeline

Browse a chronological timeline of Aspire Biopharma Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 13 Aug 2025

EPS came in at -$0.04 .

Earnings released on 14 May 2025

EPS came in at -$0.42 .

ASBP Stock Performance

Access detailed ASBP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run